Level of α-Fetoprotein Predicts Mortality Among Patients With Hepatitis C–Related Hepatocellular Carcinoma Gia L. Tyson, Zhigang Duan, Jennifer R. Kramer, Jessica A. Davila, Peter A. Richardson, Hashem B. El–Serag Clinical Gastroenterology and Hepatology Volume 9, Issue 11, Pages 989-994 (November 2011) DOI: 10.1016/j.cgh.2011.07.026 Copyright © 2011 AGA Institute Terms and Conditions
Figure 1 HCV cohort by serum AFP level at the time of HCC diagnosis. ^No serum AFP level tested between 60 days before to 30 days after HCC diagnosis. *AFP levels are shown in ng/mL. Clinical Gastroenterology and Hepatology 2011 9, 989-994DOI: (10.1016/j.cgh.2011.07.026) Copyright © 2011 AGA Institute Terms and Conditions
Figure 2 Kaplan–Meier curves of survival based on AFP category in 1480 patients with HCV-related HCC. AFP levels are shown in ng/mL. Clinical Gastroenterology and Hepatology 2011 9, 989-994DOI: (10.1016/j.cgh.2011.07.026) Copyright © 2011 AGA Institute Terms and Conditions
Figure 3 The change in serum AFP level during 2 years before to 30 days after HCC diagnosis among 1480 HCV-infected patients with HCC. ^Less than 2 recorded serum AFP levels. Clinical Gastroenterology and Hepatology 2011 9, 989-994DOI: (10.1016/j.cgh.2011.07.026) Copyright © 2011 AGA Institute Terms and Conditions